Telo Genomics Corp. (TDSGF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.78 Million CAD | -35.75% |
| 2022 | -2.05 Million CAD | -103.02% |
| 2021 | -1.19 Million CAD | 12.08% |
| 2020 | -1.15 Million CAD | -18.53% |
| 2019 | -970.61 Thousand CAD | 77.84% |
| 2018 | -4.38 Million CAD | 48.98% |
| 2017 | -7.36 Million CAD | -11582.43% |
| 2016 | -1.67 Million CAD | 34.29% |
| 2015 | -315.18 Thousand CAD | -571.6% |
| 2014 | -16.65 Thousand CAD | 77.38% |
| 2013 | -73.61 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -605.17 Thousand CAD | 26.49% |
| 2024 Q1 | -662.23 Thousand CAD | 21.6% |
| 2024 Q2 | -823.43 Thousand CAD | -24.52% |
| 2023 Q1 | -609.65 Thousand CAD | 5.09% |
| 2023 FY | - CAD | -35.75% |
| 2023 Q2 | -631.43 Thousand CAD | -3.57% |
| 2023 Q3 | -701.88 Thousand CAD | -11.16% |
| 2023 Q4 | -844.69 Thousand CAD | -20.35% |
| 2022 Q2 | -447.18 Thousand CAD | 3.41% |
| 2022 Q1 | -462.95 Thousand CAD | -69.8% |
| 2022 FY | - CAD | -103.02% |
| 2022 Q4 | -642.35 Thousand CAD | -28.21% |
| 2022 Q3 | -501 Thousand CAD | -12.04% |
| 2021 FY | - CAD | 12.08% |
| 2021 Q3 | -293.93 Thousand CAD | -13.8% |
| 2021 Q2 | -258.29 Thousand CAD | -41.49% |
| 2021 Q1 | -182.55 Thousand CAD | 37.26% |
| 2021 Q4 | -272.65 Thousand CAD | 7.24% |
| 2020 FY | - CAD | -18.53% |
| 2020 Q1 | -122.46 Thousand CAD | 16.26% |
| 2020 Q2 | -544.86 Thousand CAD | -344.92% |
| 2020 Q3 | -305.24 Thousand CAD | 43.98% |
| 2020 Q4 | -290.98 Thousand CAD | 4.67% |
| 2019 Q2 | -158.27 Thousand CAD | 71.76% |
| 2019 FY | - CAD | 77.84% |
| 2019 Q4 | -146.24 Thousand CAD | -38.4% |
| 2019 Q3 | -105.66 Thousand CAD | 33.24% |
| 2019 Q1 | -560.41 Thousand CAD | 42.09% |
| 2018 Q2 | -1.49 Million CAD | -43.69% |
| 2018 FY | - CAD | 48.98% |
| 2018 Q4 | -967.68 Thousand CAD | -22.36% |
| 2018 Q3 | -790.86 Thousand CAD | 46.98% |
| 2018 Q1 | -1.03 Million CAD | 51.17% |
| 2017 FY | - CAD | -11582.43% |
| 2017 Q3 | -2.13 Million CAD | -34.81% |
| 2017 Q1 | -3.34 Million CAD | -17406.36% |
| 2017 Q2 | -1.58 Million CAD | 52.61% |
| 2017 Q4 | -2.12 Million CAD | 0.46% |
| 2016 Q3 | -45.84 Thousand CAD | 24.74% |
| 2016 Q2 | -60.91 Thousand CAD | -2845.25% |
| 2016 Q1 | 2219.00 CAD | 126.58% |
| 2016 FY | - CAD | 34.29% |
| 2016 Q4 | -19.09 Thousand CAD | 58.35% |
| 2015 FY | - CAD | -571.6% |
| 2015 Q4 | -8348.00 CAD | -29.53% |
| 2015 Q3 | -6445.00 CAD | 63.81% |
| 2015 Q2 | -17.8 Thousand CAD | -45.55% |
| 2015 Q1 | -12.23 Thousand CAD | 53.36% |
| 2014 FY | - CAD | 77.38% |
| 2014 Q1 | -4498.00 CAD | 64.2% |
| 2014 Q2 | -6580.00 CAD | -46.29% |
| 2014 Q3 | -55.57 Thousand CAD | -744.54% |
| 2014 Q4 | -26.23 Thousand CAD | 52.79% |
| 2013 Q2 | 10.74 Thousand CAD | 243.75% |
| 2013 Q4 | -12.56 Thousand CAD | -66.59% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | -7542.00 CAD | -170.18% |
| 2013 Q1 | -7476.00 CAD | 41.98% |
| 2012 Q4 | -12.88 Thousand CAD | 85.47% |
| 2012 Q3 | -88.67 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -139.248% |
| Arrayit Corporation | -3.07 Million USD | 9.587% |
| Atlantic International Corp. | -5.38 Million USD | 48.373% |
| Biocept, Inc. | -30.24 Million USD | 90.799% |
| Bioqual, Inc. | 3.03 Million USD | 191.762% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -267.381% |
| DermTech, Inc. | -97.89 Million USD | 97.158% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.095% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 86.254% |
| iMD Companies, Inc. | -154.65 Thousand USD | -1699.088% |
| IDenta Corp. | 71.58 Thousand USD | 3986.812% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 172.516% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 7291.657% |
| InVitro International | 6680.00 USD | 41753.473% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 48.814% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -22831.037% |
| Medical Imaging Corp. | -896.74 Thousand USD | -210.285% |
| NovelStem International Corp. | -3.78 Million USD | 26.503% |
| Optigenex Inc. | -1.18 Million USD | -134.465% |
| PharmChem, Inc. | 1.05 Million USD | 364.037% |
| Proteome Sciences plc | -1.13 Million USD | -144.719% |
| Response Genetics, Inc | -19.66 Million USD | 85.851% |
| Rennova Health, Inc. | -234.81 Thousand USD | -1084.955% |
| RushNet, Inc. | -614.85 Thousand USD | -352.54% |
| ScreenPro Security Inc. | -3.43 Million USD | 18.994% |
| Stella Diagnostics Inc. | -5.7 Million USD | 51.249% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 72.907% |
| Todos Medical Ltd. | -9.39 Million USD | 70.381% |